Exact Mass: 378.2163

Exact Mass Matches: 378.2163

Found 55 metabolites which its exact mass value is equals to given mass value 378.2163, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

17beta-(Benzoyloxy)-B-norandrost-4-en-3-one

17beta-(Benzoyloxy)-B-norandrost-4-en-3-one

C25H30O3 (378.2195)


   

Nandrolone benzoate

17beta-Hydroxyestr-4-en-3-one benzoate; Nandrolone benzoate

C25H30O3 (378.2195)


   

DS-007819

21-Fluoro-11beta,17-dihydroxy-6alpha-methylpregn-4-ene-3,20-dione

C22H31FO4 (378.2206)


   
   

Neotame

3-[(3,3-Dimethylbutyl)amino]-3-[(1-methoxy-1-oxo-3-phenylpropan-2-yl)-C-hydroxycarbonimidoyl]propanoate

C20H30N2O5 (378.2155)


Potential high-intensity sweetener, sweetness variously stated to be 40 x sucrose and 7000-13000 x sucrose Neotame is an artificial sweetener made by NutraSweet that is between 7,000 and 13,000 times sweeter than sucrose (table sugar). In the European Union it is known by the E number E961. Neotame is moderately heat stable and extremely potent. Neotame is rapidly metabolized, completely eliminated, and does not accumulate in the body Potential high-intensity sweetener, sweetness variously stated to be 40 x sucrose and 7000-13000 x sucrose

   

Methyl (9Z)-6'-oxo-6,6'-diapo-6-carotenoate

Methyl (4Z,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethyl-20-oxoicosa-2,4,6,8,10,12,14,16,18-nonaenoic acid

C25H30O3 (378.2195)


Methyl (9Z)-6-oxo-6,6-diapo-6-carotenoate is a constituent of Bixa orellana (annatto) Constituent of Bixa orellana (annatto).

   

Cebranopadol

6-fluoro-N,N-dimethyl-4-phenyl-4,9-dihydro-3H-spiro[cyclohexane-1,1-pyrano[3,4-b]indole]-4-amine

C24H27FN2O (378.2107)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent Cebranopadol is an analgesic NOP and opioid receptor agonist with Kis/EC50s of 0.9 nM/13 nM, 0.7 nM/1.2 nM, 2.6 nM/17 nM, 18 nM/110 nM for human NOP, MOP, KOP and delta-opioid peptide (DOP) receptor, respectively.

   

5-epi-Triptiliocoumarin

5-epi-Triptiliocoumarin

C25H30O3 (378.2195)


   

2-Epiisotriptiliocoumarin

2-Epiisotriptiliocoumarin

C25H30O3 (378.2195)


   

walsucochin A

walsucochin A

C25H30O3 (378.2195)


   
   

bolivianine

bolivianine

C25H30O3 (378.2195)


   

beilschmiedic acid K

beilschmiedic acid K

C25H30O3 (378.2195)


   

Nassauvia chromone

Nassauvia chromone

C25H30O3 (378.2195)


   

NEOTAME

3-[(3,3-dimethylbutyl)amino]-3-[(1-methoxy-1-oxo-3-phenylpropan-2-yl)carbamoyl]propanoic acid

C20H30N2O5 (378.2155)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 2815

   

ESTRIOL BENZYL ETHER

ESTRIOL BENZYL ETHER

C25H30O3 (378.2195)


   

Methyl (9Z)-6'-oxo-6,6'-diapo-6-carotenoate

methyl (2E,4Z,6E,8E,10E,12E,14E,16E,18E)-4,8,13,17-tetramethyl-20-oxoicosa-2,4,6,8,10,12,14,16,18-nonaenoate

C25H30O3 (378.2195)


   
   
   

CHOLINE GLYCEROPHOSPHATE

CHOLINE GLYCEROPHOSPHATE

C13H35N2O8P (378.2131)


   

4,4-BIPHENYLDIBORONIC ACID BIS(NEOPENTYL GLYCOL) ESTER

4,4-BIPHENYLDIBORONIC ACID BIS(NEOPENTYL GLYCOL) ESTER

C22H28B2O4 (378.2174)


   
   

(2-(DICYCLOHEXYLPHOSPHINO)PHENYL)(PHENYL)METHANONE

(2-(DICYCLOHEXYLPHOSPHINO)PHENYL)(PHENYL)METHANONE

C25H31OP (378.2112)


   

CALCIUM CYCLOHEXANEBUTYRATE

CALCIUM CYCLOHEXANEBUTYRATE

C20H34CaO4 (378.2083)


   

3-O-Benzyl Estriol

3-O-Benzyl Estriol

C25H30O3 (378.2195)


   
   
   

2-Propenoic acid, 3-(4,5,6,7-tetrahydro-4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2-benzofuranyl)-

2-Propenoic acid, 3-(4,5,6,7-tetrahydro-4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-2-benzofuranyl)-

C25H30O3 (378.2195)


   

21-Fluoro-11beta,17-dihydroxy-6alpha-methylprogesterone

21-Fluoro-11beta,17-dihydroxy-6alpha-methylpregn-4-ene-3,20-dione

C22H31FO4 (378.2206)


   

Cebranopadol

Cebranopadol

C24H27FN2O (378.2107)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent Cebranopadol is an analgesic NOP and opioid receptor agonist with Kis/EC50s of 0.9 nM/13 nM, 0.7 nM/1.2 nM, 2.6 nM/17 nM, 18 nM/110 nM for human NOP, MOP, KOP and delta-opioid peptide (DOP) receptor, respectively.

   

19-Nortestosterone benzoate/nandrolone benzoate

19-Nortestosterone benzoate/nandrolone benzoate

C25H30O3 (378.2195)


   

1-Pentadecylglycerone 3-phosphate(2-)

1-Pentadecylglycerone 3-phosphate(2-)

C18H35O6P-2 (378.2171)


   

(9E)-12-(phosphonooxy)octadecenoic acid

(9E)-12-(phosphonooxy)octadecenoic acid

C18H35O6P (378.2171)


   

(9Z)-12-(phosphonooxy)octadecenoic acid

(9Z)-12-(phosphonooxy)octadecenoic acid

C18H35O6P (378.2171)


   

Methyl (9Z)-6-oxo-6,6-diapo-6-carotenoate

Methyl (9Z)-6-oxo-6,6-diapo-6-carotenoate

C25H30O3 (378.2195)


   

1-Pentadecylglycerone 3-phosphate(2-)

1-Pentadecylglycerone 3-phosphate(2-)

C18H35O6P (378.2171)


A 1-alkylglycerone 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-pentadecylglycerone 3-phosphate; major species at pH 7.3.

   
   

methyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethyl-20-oxoicosa-2,4,6,8,10,12,14,16,18-nonaenoate

methyl (6e,8e,10e,12e,14e,16e,18e)-4,8,13,17-tetramethyl-20-oxoicosa-2,4,6,8,10,12,14,16,18-nonaenoate

C25H30O3 (378.2195)


   

13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 2-methylbut-2-enoate

13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 2-methylbut-2-enoate

C20H30N2O5 (378.2155)


   

(2r,4r)-2-[(1e)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

(2r,4r)-2-[(1e)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

C25H30O3 (378.2195)


   

(4ar,6r,6ar,11ar,11br)-9-ethynyl-6-hydroxy-8-methoxy-4,4,6a,10,11b-pentamethyl-4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-3-one

(4ar,6r,6ar,11ar,11br)-9-ethynyl-6-hydroxy-8-methoxy-4,4,6a,10,11b-pentamethyl-4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-3-one

C25H30O3 (378.2195)


   

(2r,4s)-2-[(1e)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,6-dimethyl-2h,3h-pyrano[2,3-b]chromen-5-one

(2r,4s)-2-[(1e)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,6-dimethyl-2h,3h-pyrano[2,3-b]chromen-5-one

C25H30O3 (378.2195)


   

(1r,2s,4r,6s,8r,9s,10s,14s,16r)-9,13,17,17-tetramethyl-5-methylidene-18,22-dioxaheptacyclo[12.8.0.0¹,¹⁰.0²,¹⁶.0²,²⁰.0⁴,⁹.0⁶,⁸]docosa-12,19-dien-21-one

(1r,2s,4r,6s,8r,9s,10s,14s,16r)-9,13,17,17-tetramethyl-5-methylidene-18,22-dioxaheptacyclo[12.8.0.0¹,¹⁰.0²,¹⁶.0²,²⁰.0⁴,⁹.0⁶,⁸]docosa-12,19-dien-21-one

C25H30O3 (378.2195)


   

9-ethynyl-6-hydroxy-8-methoxy-4,4,6a,10,11b-pentamethyl-4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-3-one

9-ethynyl-6-hydroxy-8-methoxy-4,4,6a,10,11b-pentamethyl-4ah,5h,6h,11h,11ah-cyclohexa[a]fluoren-3-one

C25H30O3 (378.2195)


   

(1r,2s,4s,9r,10r,13s,17r)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

(1r,2s,4s,9r,10r,13s,17r)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

C20H30N2O5 (378.2155)


   

(1s,2s,4s,9s,10r,13s,17s)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

(1s,2s,4s,9s,10r,13s,17s)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

C20H30N2O5 (378.2155)


   

2-(4,8-dimethylnona-1,3,7-trien-1-yl)-2,3,9-trimethyl-3h-furo[3,2-c]chromen-4-one

2-(4,8-dimethylnona-1,3,7-trien-1-yl)-2,3,9-trimethyl-3h-furo[3,2-c]chromen-4-one

C25H30O3 (378.2195)


   

(1s,2s,4s,9s,10r,13s,17r)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

(1s,2s,4s,9s,10r,13s,17r)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2z)-2-methylbut-2-enoate

C20H30N2O5 (378.2155)


   

(2s,4r)-2-[(1e)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

(2s,4r)-2-[(1e)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

C25H30O3 (378.2195)


   

2-(2,6-dimethylhepta-1,5-dien-1-yl)-4-ethenyl-4,6-dimethyl-2h,3h-pyrano[2,3-b]chromen-5-one

2-(2,6-dimethylhepta-1,5-dien-1-yl)-4-ethenyl-4,6-dimethyl-2h,3h-pyrano[2,3-b]chromen-5-one

C25H30O3 (378.2195)


   

(2r,3r)-2-[(1e,3e)-4,8-dimethylnona-1,3,7-trien-1-yl]-2,3,9-trimethyl-3h-furo[3,2-c]chromen-4-one

(2r,3r)-2-[(1e,3e)-4,8-dimethylnona-1,3,7-trien-1-yl]-2,3,9-trimethyl-3h-furo[3,2-c]chromen-4-one

C25H30O3 (378.2195)


   

(1s,2s,4s,9s,10r,13s,17r)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2e)-2-methylbut-2-enoate

(1s,2s,4s,9s,10r,13s,17r)-13,17-dihydroxy-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl (2e)-2-methylbut-2-enoate

C20H30N2O5 (378.2155)


   

2-(2,6-dimethylhepta-1,5-dien-1-yl)-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

2-(2,6-dimethylhepta-1,5-dien-1-yl)-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

C25H30O3 (378.2195)


   

(2s,4r)-2-[(1z)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

(2s,4r)-2-[(1z)-2,6-dimethylhepta-1,5-dien-1-yl]-4-ethenyl-4,10-dimethyl-2h,3h-pyrano[3,2-c]chromen-5-one

C25H30O3 (378.2195)